PEAK PHARMACEUTICALS, INC. (RMHI) Operating cash flow 2013–2022
PEAK PHARMACEUTICALS, INC. (RMHI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$68,553FY2022 · since FY2013: -$15,567 → -$68,553
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$68,553 | -380.9% |
| FY2021 | -$14,256 | -11879.8% |
| FY2020 | -$119 | +93.2% |
| FY2019 | -$1,743 | +96.0% |
| FY2018 | -$43,721 | -138.7% |
| FY2017 | -$18,313 | +90.9% |
| FY2016 | -$200,352 | +19.1% |
| FY2015 | -$247,589 | +73.5% |
| FY2014 | -$933,475 | -5896.5% |
| FY2013 | -$15,567 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RMHI financial trends
RMHI RevenueRMHI Net incomeRMHI Net marginRMHI Gross profitRMHI Gross marginRMHI Operating incomeRMHI Operating marginRMHI Free cash flowRMHI Capital expendituresRMHI Return on equityRMHI Stock buybacksRMHI Dividends paidRMHI Total assetsRMHI Total liabilitiesRMHI Shareholders’ equityRMHI overview →